Cellectar is so proud of you Kate! #PatientsEU2024 #Waldenstroms #clinicaltrials
Looking forward to sharing the CLOVER-WaM experience with Erica Mercado #PatientsEU2024 #Waldenstroms #clinicaltrials
Cellectar Biosciences, Inc.’s Post
More Relevant Posts
-
Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER-WaM Pivotal Trial and Waldenstrom’s Macroglobulinemia Market Landscape: https://bit.ly/3XGT53f #pivotaltrial #clinicalresearch #cloverwam #waldenstrommacrocglobulinemia #iopofosine #marketlandscape #KOLEvent
-
-
Our Chief Operations Officer Jarrod Longcor is participating in a panel at #SNMMI2024 and will be able to share Cellectar's journey, including information about iopofosine131. We are so proud to be a part of this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI)'s Annual Meeting and to have Jarrod speak!
As the premier radiotherapeutics, nuclear medicine and imaging conference, it is a real privilege to be able to participate in one of the panels and to share #Cellectar's and #iopofosine I 131's story at #SNMMI.
-
We are excited to attend the 2024 SNMMI meeting in Toronto. come learn more about Cellectar Biosciences at booth #1700! #SNMMIAnnualMeeting #SNMMI2024 #Toronto #NuclearMedicine #Radiotherapeutics Society of Nuclear Medicine and Molecular Imaging (SNMMI)
-
-
Cellectar Biosciences and City of Hope Cancer Center (City of Hope) Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides https://bit.ly/3WZY3Yo #MycosisFungoides #Collaboration #Biopharma
-
-
As we head into the long Memorial Day weekend, we honor the brave men and women who made the ultimate sacrifice defending our nation and our freedoms. Take a moment to reflect on their service and remember those who gave their lives for our country. We wish everyone a safe, fun, and meaningful Memorial Day. #MemorialDay #HonorThem #FreedomIsntFree #MemorialDayWeekend #Veterans
-
-
Cellectar Biosciences released its Q1 2024 financial results and corporate update this morning. See the associated presentation and listen to the audio of this morning’s call here: https://lnkd.in/gKiR5XwQ #FinancialResults #Biopharma #Oncology #Q12024 #radiopharmaceuticals #RPTs #Iopofosine
-
-
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update https://bit.ly/3V9MUDn #FinancialResults #Biopharma #Oncology #Q12024
-
-
Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day https://bit.ly/3JPP2tt #radiopharmaceuticals #GuggenheimHealthcareTalks2024 #RPTs #Iopofosine #CLR131
-
-
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024 https://bit.ly/3JRVekq #ConferenceCall #Waldenstroms #Biopharma #OncologyResearch
-
As a WM patient I appreciate what you do! Thank you